Moderna, Inc. 4

Moderna President Stephen Hoge exercised options for 53,336 shares at $19.15 and sold 53,336 shares of Moderna common stock at $67.60 on July 15, 2026 under a Rule 10b5-1 plan.

On July 15, 2026, Moderna President Stephen Hoge exercised two tranches of stock options for a total of 53,336 shares of common stock at an exercise price of $19.15 per share (37,226 shares and 16,110 shares), and on the same day sold 53,336 shares of Moderna common stock at $67.60 per share pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on November 13, 2025. The option exercises (Form 4 code “M”) reflect fully vested, exercisable options converted into common stock, while the sale (code “S”) appears to monetize the exercised shares at a substantial spread between the exercise and sale prices. Following these transactions, Hoge reported direct ownership of 1,483,848 Moderna common shares, along with indirect holdings of 4,116 shares through Valhalla, LLC and 151,933 shares held by a trust for the benefit of his spouse and children, for which he disclaims beneficial ownership except to the extent of any pecuniary interest.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

4

Source Type

fda

Accession

0001682852-26-000141

Alert Tier

6